NDC 0061-0387 - Otomax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-0387
- Package NDCs from labels
- 0061-0387-02, 0061-0387-03, 0061-0387-17, 0061-0387-08, 0061-0387-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Otomax - Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp. | 2026-05-18 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-0387-01 | Otomax | 215 g in 1 BOTTLE, PLASTIC | OINTMENT | 215 | 10 | |
| 0061-0387-01 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-02 | Otomax | 7.5 g in 1 TUBE | OINTMENT | 7.5 | 10 | |
| 0061-0387-02 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 15 g in 1 TUBE | OINTMENT | 15 | 10 | |
| 0061-0387-08 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-08 | Otomax | 30 g in 1 BOTTLE, PLASTIC | OINTMENT | 30 | 10 | |
| 0061-0387-17 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-17 | Otomax | 15 g in 1 BOTTLE, DISPENSING | OINTMENT | 15 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Betamethasone valerate | ACTIVE INGREDIENT | 9IFA5XM7R2 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Betamethasone | ACTIVE MOIETY | 9842X06Q6M | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 3a6677a6-def5-443e-82bc-c185d41f03b7 | 2022-06-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 036706f1-0a24-4765-9a62-820ad64934be | 2022-06-01 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | 3d235926-6f17-4aa5-be82-7f1b4357e247 | 2022-06-01 | Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Padagis US LLC | 3f57ef51-8202-4d0b-95a8-d2df468b8d9a | 2022-05-31 | Warnings, Adverse reactions | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Cosette Pharmaceuticals, Inc. | 784476d2-5e5c-fdba-a677-8973a777b5ef | 2022-05-05 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | a54e5c95-609d-4d66-9573-5d1ac78fa58f | 2022-03-04 | Warnings, Adverse reactions | 8X7386QRLV |
| Micomitin Antifungal | CLOTRIMAZOLE | PureTek Corporation | dd05f5f9-2412-1295-e053-2995a90acb96 | 2022-02-14 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | c62264a9-cea3-4461-9399-35d8931d38d5 | 2022-02-01 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Hikma Pharmacuticals USA USA Inc. | 0bc4b876-ddee-4f03-b44f-544348739a26 | 2021-07-30 | Warnings, Adverse reactions | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | cf4386ba-c62a-4ee8-ab59-1bb2e737a5da | 2021-05-01 | Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 2a64b65b-8a49-45ea-9464-2269751c075c | 2021-04-01 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | c6e4bf5f-f6d6-489e-9286-c30568c601b7 | 2021-01-01 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Glenmark Pharmaceuticals Inc. USA | 8dcd24cb-e568-428a-88ac-737d115cc54d | 2020-11-09 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE TOPICAL | Novitium Pharma LLC | 02df90b9-4879-4e73-b03a-0e96f3d099ea | 2020-08-13 | Warnings, Adverse reactions | G07GZ97H65 |
| Gentak | GENTAMICIN SULFATE | Proficient Rx LP | aebfe247-cdf7-4acb-97b3-6d4341d7c815 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 2098faaa-7f60-4640-8c37-19456ebba653 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.